Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Items 701–800 of 1,013
Applications of mesenchymal stem cell technology in bovine species
Hill, A. B. T., Bressan, F. F., Murphy, B. D., & Garcia, J. M. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1145-9 · Cited by 67
Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics?
Hoogduijn, M. J., Betjes, M. G. H., & Baan, C. C. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000036 · Cited by 77
Immunomodulatory Nature and Site Specific Affinity of Mesenchymal Stem Cells: a Hope in Cell Therapy
Lotfinejad, P., Shamsasenjan, K., Movassaghpour, A. A., Majidi, J., & Baradaran, B. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2014.002 · Cited by 70
“In addition to the bone marrow,(21,22) MSCs have been found in other sources, including liver,(23) lung,(24,25) brain,(26) adipose tissue, 29 peripheral blood,(30) cornea,(31) synovium,(32) thymus,(33) dental pulp,(34,35) periosteum,(36) tendon,(37) spleen,(33) fallopian tube,(38) placenta,(39,40) amniotic fluid,(41)…”
BackgroundLyu, Z., Xin, M., Oyston, D. R., Xue, T., Kang, H., Wang, X., Wang, Z., & Wang, Z. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155354 · Cited by 71
Tang, C., Russell, P. J., Martiniello‐Wilks, R., Rasko, J. E. J., & Khatri, A. (2010) · Stem Cells · doi:10.1002/stem.473 · Cited by 71
Boquest, A. C., Noer, A., Sørensen, A. L., Vekterud, K., & Collas, P. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0428 · Cited by 73
Burra, P., Arcidiacono, D., Bizzaro, D., Chioato, T., Liddo, R. D., Banerjee, A., Cappon, A., Bo, P., Conconi, M. T., Parnigotto, P. P., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-88 · Cited by 69
Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors
Amara, I., Touati, W., Beaune, P. H., & de Waziers, I. (2014) · Biochimie · doi:10.1016/j.biochi.2014.06.016 · Cited by 68
Roles of Hypoxia During the Chondrogenic Differentiation of Mesenchymal Stem Cells
Shang, J., Liu, H., Li, J., & Zhou, Y. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666131230142459 · Cited by 67
Kang, M., Kim, H., Jung, Y., Kim, Y., Hong, S., Kim, M., Baek, K., Kim, C., & Rhyu, M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21291 · Cited by 82
“…the boundaries of CpG islands and at the nonisland CpG sites close to the transcription start sites of the genes lacking CpG islands [Kang et al., 2006; Kim et al., 2006], which are expected to influence the phenotype plasticity of mesenchymal cells through the DNA methylation-dependent mechanism.”
BackgroundMethodInfluentialCaseiro, A. R., Pereira, T., Ivanova, G. I., Luís, A. L., & Maurício, A. C. (2016) · Stem Cells International · doi:10.1155/2016/9756973 · Cited by 70
“Nonetheless, MSCs from distinct sources are not completely identical, differing in, as an example, their differentiation propensity [64, 68–70] and secretory profiles [71].”
InfluentialModifiers of mesenchymal stem cell quantity and quality
Russell, A. L., Lefavor, R., Durand, N., Glover, L., & Zubair, A. C. (2018) · Transfusion · doi:10.1111/trf.14597 · Cited by 65
Regenerative Medicine and Rehabilitation for Tendinous and Ligamentous Injuries in Sport Horses
Ortved, K. F. (2018) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2018.04.012 · Cited by 73
Fabre, H., Ducret, M., Degoul, O., Rodríguez, J., Perrier‐Groult, E., Aubert‐Foucher, E., Pasdeloup, M., Auxenfans, C., McGUCKIN, C. P., Forraz, N., et al. (2019) · Stem Cells International · doi:10.1155/2019/2186728 · Cited by 74
“They may provide an alternative to chondrocytes, but their properties, including the ability of chondrogenesis, are reported to depend on their source [4, 20, 21].”
BackgroundApplication of Tonsil-Derived Mesenchymal Stem Cells in Tissue Regeneration: Concise Review
Oh, S.-Y., Choi, Y. M., Kim, H. Y., Park, Y. S., Jung, S., Park, J., Woo, S., Ryu, K., Kim, H. S., & Jo, I. (2019) · Stem Cells · doi:10.1002/stem.3058 · Cited by 68
Jang, S. G., Lee, J., Hong, S.-M., Kwok, S., Cho, M., & Park, S. (2019) · Rheumatology · doi:10.1093/rheumatology/kez631 · Cited by 71
Stem cell-based therapy for pulmonary fibrosis
Cheng, W., Zeng, Y., & Wang, D. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03181-8 · Cited by 65
Kim, D. S., Lee, M. W., Lee, T.-H., Sung, K. W., Koo, H. H., & Yoo, K. H. (2017) · Biomedical Reports · doi:10.3892/br.2017.845 · Cited by 65
Wu, J., Sun, Y. W., Block, T. J., Marinkovic, M., Zhang, Z.-L., Chen, R., Yin, Y., Song, J., Dean, D. D., Lu, Z., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0437-6 · Cited by 65
De Toni, F., Poglio, S., Youcef, A. B., Cousin, B., Pflumio, F., Bourin, P., Casteilla, L., & Laharrague, P. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0044 · Cited by 62
“It has been reported that culture conditions have a major impact not only on the composition of human stromal cell preparations [15] but also on the proteome of cultured cells [4,16].”
Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells
Kopher, R. A., Penchev, V. R., Islam, M. S., Hill, K. L., Khosla, S., & Kaufman, D. S. (2010) · Bone · doi:10.1016/j.bone.2010.06.020 · Cited by 67
“Because fetal- and adult-derived MSCs appear to have some limitations, including disparate differentiation tendencies [17-21], we postulate that hESC-derived MSCs will provide improved opportunities for regenerative medicine.”
BackgroundPokrywczyńska, M., Gubanska, I., Drewa, G., & Drewa, T. A. (2015) · BioMed Research International · doi:10.1155/2015/613439 · Cited by 71
“MSCs can be found in many adult tissues and they are concerned as of the most attractive stem cell type for the regeneration of the damaged tissues [82].”
BackgroundLee, J., Abdeen, A. A., Tang, X., Saif, T. A., & Kilian, K. A. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.037 · Cited by 68
Bogers, S. H. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00070 · Cited by 73
Nitkin, C. R., Rajasingh, J., Pisano, C., Besner, G. E., Thébaud, B., & Sampath, V. (2019) · Pediatric Research · doi:10.1038/s41390-019-0425-5 · Cited by 69
Paracrine effects of mesenchymal stem cells on the activation of keratocytes
Jiang, Z., Liu, G., Meng, F., Wang, W., Hao, P., Xiang, Y., Wang, Y., Han, R., Li, F., Wang, L., et al. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-310012 · Cited by 64
Basic Science and Clinical Application of Stem Cells in Veterinary Medicine
Ribitsch, I., Burk, J., Delling, U., Geißler, C., Gittel, C., Jülke, H., & Brehm, W. (2010) · Springer eBooks · doi:10.1007/10_2010_66 · Cited by 74
“[33] demonstrated a higher proliferation potential of human adipose tissue derived MSCs.”
BackgroundNie, C., Zhang, G., Yang, D., Liu, T., Liu, D., Xu, J., & Zhang, J. (2012) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1622 · Cited by 65
“However, due to difficulties in obtaining sufficient BMSCs, adipose-derived stem cells (ASCs) lately represent an alternative source of pluripotent cells (Kern et al., 2006; Goh et al., 2007).”
BackgroundKlotz, B. J., Mentrup, B., Regensburger, M., Zeck, S., Schneidereit, J., Schupp, N., Linden, C., Merz, C., Ebert, R., & Jakob, F. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029959 · Cited by 66
“CPDs were calculated as described previously [38–39].”
Vishnubalaji, R., Manikandan, M., Al-Nbaheen, M. S., Kadalmani, B., Aldahmash, A. M., & Alajez, N. M. (2012) · BMC Developmental Biology · doi:10.1186/1471-213x-12-7 · Cited by 65
Stem Cell-Based Therapies for Liver Diseases: State of the Art and New Perspectives
Piscaglia, A. C., Campanale, M., Gasbarrini, A., & Gasbarrini, G. B. (2010) · Stem Cells International · doi:10.4061/2010/259461 · Cited by 69
“ATSCs are similar to BM-MSCs in terms of surface antigen marker profile and differentiation potential, and ATSCs have been reported to exert an even higher proliferative capacity in vitro [76, 77].”
BackgroundLiu, X., Fang, Q., & Kim, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157099 · Cited by 69
“Mesenchymal stem cells (MSCs) are multi-potent stem cells that have fibroblast-like morphology and the capacity to differentiate into chondrocytes, osteoblasts, adipocytes and muscle cells under different micro-environmental conditions, culture media, and supplements [2, 3].”
BackgroundInjectable osteogenic and angiogenic nanocomposite hydrogels for irregular bone defects
Priya, M. V., Sivshanmugam, A., Boccaccini, A. R., Goudouri, O., Sun, W., Hwang, N. S.-Y., Deepthi, S., Nair, S. V., & Jayakumar, R. (2016) · Biomedical Materials · doi:10.1088/1748-6041/11/3/035017 · Cited by 64
“Cells grown without any gel and the control gel showed a typical increase in ALP expression after 14 d of culture (Kern et al 2006).”
BackgroundAdipose Tissue-Derived Stromal Cells for Wound Healing
Goodarzi, P., Alavi-Moghadam, S., Sarvari, M., Tayanloo-Beik, A., Falahzadeh, K., Aghayan, H. R., Payab, M., Larijani, B. A., Gilany, K., Rahim, F., et al. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_220 · Cited by 71
Shen, W. X., Sun, B., Zhou, C., Ming, W., Zhang, S., & Wu, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15792 · Cited by 63
Origins of the breast milk‐derived cells; an endeavor to find the cell sources
Sani, M., Hosseini, S. M., Salmannejad, M., Aleahmad, F., Ebrahimi, S., Jahanshahi, S., & Talaei‐Khozani, T. (2015) · Cell Biology International · doi:10.1002/cbin.10432 · Cited by 63
“Mesenchymal stem cell derived from different sources such as bonemarrow, adipose tissue,Wharton’s jelly, amniotic fluid, menstrual blood, etc. have been isolated and described widely in recent years (Kern et al., 2006; Patel et al., 2008; Ohishi and Schipani, 2010; Pirjali et al., 2013).”
BackgroundBaer, P. C., Bereiter‐Hahn, J., Missler, C., Brzoska, M., Schubert, R., Gauer, S., & Geiger, H. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00572.x · Cited by 68
Lineage-Specific Promoter DNA Methylation Patterns Segregate Adult Progenitor Cell Types
Sørensen, A. L., Timoskainen, S., West, F. D., Vekterud, K., Boquest, A. C., Ährlund-Richter, L., Stice, S. L., & Collas, P. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0309 · Cited by 62
“ASCs and BMMSCs differ, however, in the expression of CD90, CD105, CD106 [2] and of adhesion molecules [1].”
Khairoun, M., & S Korevaar, S. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s6-001 · Cited by 62
“The expanded MSC from healthy BM and adipose tissue donors all expressed the common MSC markers CD73, CD90, CD105 and CD166 (data not shown).”
BackgroundInfluentialIntrinsic Growth Deficiencies of Mesenchymal Stromal Cells in Myelodysplastic Syndromes
Aanei, C. M., Flandrin‐Gresta, P., Eloae, F. Z., Carasevici, E., Guyotat, D., Wattel, E., & Campos, L. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0390 · Cited by 63
Stem cell therapies for treating osteoarthritis: Prescient or premature?
Whitworth, D. J., & Banks, T. A. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.09.024 · Cited by 78
“…a common feature of MSCs, irrespective of species-of-origin, is that they 229 represent a very small fraction of the cells isolated from both bone marrow and adipose tissue 230 (0.001-0.01% and 0.05%, respectively) for human tissues (Kern et al., 2006; Bieback et al., 231 Page 10 of 35 2008).”
BackgroundResultInfluentialGeburek, F., Roggel, F., van Schie, H. T. M., Beineke, A., Estrada, R., Weber, K., Hellige, M., Röhn, K., Jagodzinski, M., Welke, B., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0564-8 · Cited by 63
“The advantages of adipose tissue over bone marrow are that it is widely available and easily accessible, and its MSC content is higher with a higher proliferation capacity of AT-MSCs [32] and a slower senescence than that of bone marrow mesenchymal stromal cells (BM-MSCs) [27, 33, 34].”
Khojasteh, A., Kheiri, L., Behnia, H., Tehranchi, A., Nazeman, P., Nadjmi, N., & Soleimani, M. (2017) · BioMed Research International · doi:10.1155/2017/6560234 · Cited by 63
“A combination of BMMSCs and platelet-derived growth factors demonstrated 51% new bone in secondary alveoloplasty in cleft patients [6].”
ResultInfluentialWu, C., Chen, L., Huang, Y., Huang, Y., Parolini, O., Zhong, Q., Tian, X., & Deng, L. (2018) · Stem Cells International · doi:10.1155/2018/7131532 · Cited by 63
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
Bajetto, A., Thellung, S., Dellacasagrande, I., Pagano, A., Barbieri, F., & Florio, T. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0161 · Cited by 65
“sources share the minimum standard criteria set by ISCT, many studies suggest that each tissue of origin has a different MSC content, and influences in vitro MSC features, such as the proliferative rate, the differentiation potential, and the marker expression profile (Table 1).(18,19)”
BackgroundPhytochemicals impact on osteogenic differentiation of mesenchymal stem cells
Sharifi, S., Moghaddam, F. A., Abedi, A., Dizaj, S. M., Ahmadian, S., Abdolahinia, E. D., Khatibi, S. M. H., & Samiei, M. (2020) · BioFactors · doi:10.1002/biof.1682 · Cited by 65
Kallifatidis, G., Beckermann, B. M., Groth, A., Schubert, M., Apel, A., Khamidjanov, A., Ryschich, E., Wenger, T., Wagner, W., Diehlmann, A., et al. (2008) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701097 · Cited by 63
Exploring the mesenchymal stem cell niche using high throughput screening
Ghaemi, S. R., Harding, F. J., Delalat, B., Gronthos, S., & Voelcker, N. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.022 · Cited by 71
“MSC colonies arising from tissue) [29,38]”
Khalil, C., Moussa, M., Azar, A., Tawk, J., Habbouche, J., Salameh, R., Ibrahim, A., & Alaaeddine, N. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0546-9 · Cited by 57
Bioinspired injectable hydrogels for bone regeneration
Tang, X., Zhou, F., Wang, S., Wang, G., Bai, L., & Su, J. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.10.032 · Cited by 64
“BMSCs were the first MSCs to be reported [224] and have been successfully used in tissue engineering and disease treatment [225–227], holding great promise in bone regeneration [228].”
Naji, A., Rouas‐Freiss, N., Dürrbach, A., Carosella, E. D., Sensebé, L., & Deschaseaux, F. (2013) · Stem Cells · doi:10.1002/stem.1494 · Cited by 68
Zhang, H., Fan, J., Cai, Y., Zhao, S.-J., Xue, S., Lin, J.-H., Jiang, X., & Xu, R. (2009) · Differentiation · doi:10.1016/j.diff.2009.09.002 · Cited by 62
Wood, J. A., Chung, D.-J., Park, S. A., Zwingenberger, A. L., Reilly, C. M., Ly, I., Walker, N. J., Vernau, W., Hayashi, K., Wisner, E. R., et al. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0166 · Cited by 62
Multipotent adipose stromal cells and breast cancer development: Think globally, act locally
Zhao, M., Dumur, C. I., Holt, S. E., Beckman, M. J., & Elmore, L. W. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20675 · Cited by 66
“Based on the striking similarities we (Figure 1) and others [16] have discovered between BM-MSCs and breast-derived ASC, it was not surpris-”
ResultStem cell plasticity: Learning from hepatogenic differentiation strategies
Banaś-Ząbczyk, A., Yamamoto, Y., Teratani, T., & Ochiya, T. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21330 · Cited by 66
“Even though isolated from different tissues, these cells share similar surface markers with small variability (SH3 , CD29 , CD44 , CD71 , CD90 , CD105 , CD106 , CD120a , CD124 , CD14 , CD31 , CD34 , and CD45 ) (Kern et al., 2006; Wagner et al., 2005).”
Kočí, Z., Turnovcová, K., Dubský, M., Baranovičová, L., Holáň, V., Chudíčková, M., Syková, E., & Kubinová, Š. (2014) · Cell Biochemistry and Function · doi:10.1002/cbf.3056 · Cited by 64
Karlupia, N., Manley, N. C., Prasad, K., Schäfer, R., & Steinberg, G. K. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt434 · Cited by 63
“Further, because of phenotypical and functional heterogeneity within MSC preparations and variations between MSC donors, it would be informative to include multiple MSC preparations from multiple donors in MSC studies [102,103].”
BackgroundQuarto, N., Senarath-Yapa, K., Renda, A., & Longaker, M. T. (2015) · Stem Cells · doi:10.1002/stem.1907 · Cited by 60
Song, M., Jue, S., Cho, Y., & Kim, E. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23569 · Cited by 62
“Additionally, the number, proliferation, and differentiation potential of hMSCs are limited, commensurate with increasing age (Kern et al., 2006; Martens et al., 2013).”
BackgroundKol, A., Wood, J. A., Holt, D. D. C., Gillette, J. A., Bohannon, L. K., Puchalski, S. M., Walker, N. J., Clark, K. C., Watson, J. L., & Borjesson, D. L. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0050-0 · Cited by 64
Maurmann, N., Pereira, D. P., Burguêz, D., Pereira, F. D. A. D. S., Neto, P. I., Rezende, R. A., Gamba, D., da Silva, J. V. L., & Pranke, P. H. L. (2017) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/aa6308 · Cited by 69
“Favorable characteristics of human umbilical cord mesenchymal stem cells (UCMSC) include good differentiation and proliferation capabilities (Kern et al 2006, Baksh et al 2007).”
BackgroundIm, G. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36089 · Cited by 64
Yang, J.-A., Chung, H., Won, C. H., & Sung, J.-H. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712591003610598 · Cited by 64
“Adipose-derived stem cells (ASCs) are becoming an important candidate cell population for use in stem cell medicine [6-8], and ASCs have been successfully used to correct skin defects [4,9,10].”
BackgroundLiu, Y., & Holmes, C. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648098 · Cited by 64
The Role of Adipose Stem Cells in Bone Regeneration and Bone Tissue Engineering
Mende, W., Götzl, R., Kubo, Y., Pufe, T., Ruhl, T., & Beier, J. P. (2021) · Cells · doi:10.3390/cells10050975 · Cited by 64
“Moreover, ASCs have a higher proliferation capacity and more colony-forming units compared to bmMSCs [14,15].”
BackgroundResultLiu, C., Xu, Y., Lu, Y., Du, P., Li, X., Wang, C., Guo, P., Diao, L., & Lu, G. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02934-9 · Cited by 65
Liu, L., Chiu, P. W. Y., Lam, P. K., Poon, C. C. Y., Lam, C. C. H., Ng, E. K. W., & Lai, P. B. S. (2015) · British journal of surgery · doi:10.1002/bjs.9724 · Cited by 61
Fetal adnexa derived stem cells from domestic animal: progress and perspectives
Cremonesi, F., Corradetti, B., & Lange-Consiglio, A. (2011) · Theriogenology · doi:10.1016/j.theriogenology.2010.12.032 · Cited by 75
“In veterinary medicine, MSCs have been harvested successfully from a variety of tissues including, but not limited to, bone marrow [6,20–26], skin [27], adipose tissue [22,26] and peripheral blood [28,29].”
BackgroundResultInfluentialCharacterization of mesenchymal stromal cells derived from full-term umbilical cord blood
Manca, M. F., Zwart, I., Beo, J., Palasingham, R., Jen, L. S., Navarrete, R., Girdlestone, J., & Navarrete, C. (2008) · Cytotherapy · doi:10.1080/14653240701732763 · Cited by 67
Aloysious, N., & Nair, P. D. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0615 · Cited by 63
“Harvesting adipose tissue and isolating stem cells from it is an easy procedure(26) and the yield of stem cells is more when compared with other sources like bone marrow.(27,28) Population doubling time was calculated and the results are shown in Figure 1b.”
Chae, D.-S., Han, S.-H., Son, M., & Kim, S. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.01.006 · Cited by 64
The challenges of promoting osteogenesis in segmental bone defects and osteoporosis
Ball, A. N., Donahue, S. W., Wojda, S. J., McIlwraith, C. W., Kawcak, C. E., Ehrhart, N. P., & Goodrich, L. R. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23845 · Cited by 64
Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis
Han, H. S., Lee, H., You, D., Nguyen, V. Q., Song, D.-G., Oh, B. H., Shin, S., Choi, J. S., Kim, J. D., Pan, C.-H., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.042 · Cited by 58
Cell therapy in acute respiratory distress syndrome
Horie, S., Gonzalez, H. E., Laffey, J. G., & Masterson, C. H. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.08.28 · Cited by 61
Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?
Isaković, J., Šerer, K., Barišić, B., & Mitrečić, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1139359 · Cited by 66
“The researchers designed a three-dimensional hydrogel scaffold based on self-assembled RADA16 peptides containing SPIONs, which was used to grow hAT-MSCs.”
BackgroundInfluentialPerrini, S., Ficarella, R., Picardi, E., Cignarelli, A., Barbaro, M. P. F., Nigro, P., Peschechera, A., Palumbo, O., Carella, M., Fazio, M. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057892 · Cited by 63
“) comparative analysis of bone marrow and adipose tissue-derived mesenchymal stromal cells in in vitro adipogenic, chondrogenic or osteogenic differentiation [32]; [33], and iii.”
Stability of neural differentiation in human adipose derived stem cells by two induction protocols
Ahmadi, N., Razavi, S., Kazemi, M., & Oryan, S. (2011) · Tissue and Cell · doi:10.1016/j.tice.2011.11.006 · Cited by 60
Chang, Y.-J., Hwang, S., Tseng, C., Cheng, F.-C., Huang, S.-H., Hsu, L., Hsu, L., & Tsai, M. (2010) · Cells Tissues Organs · doi:10.1159/000295774 · Cited by 65
“However, MSCs derived from adult tissue may exhibit various limitations related to donor age and tissue source [Rao and Mattson, 2001; Kern et al., 2006; Zhou et al., 2008].”
BackgroundMareschi, K., Rustichelli, D., Comunanza, V., Fazio, R. D., Cravero, C., Morterra, G., Martinoglio, B., Médico, E., Carbone, E., Benedetto, C., et al. (2009) · Cytotherapy · doi:10.1080/14653240902974024 · Cited by 62
Overath, J. M., Gauer, S., Obermüller, N., Schubert, R., Schäfer, R., Geiger, H., & Baer, P. C. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.002 · Cited by 60
Low Serum Cultured Adipose Tissue-Derived Stromal Cells Ameliorate Acute Kidney Injury in Rats
Katsuno, T., Ozaki, T., Saka, Y., Furuhashi, K., Kim, H., Yasuda, K., Yamamoto, T., Sato, W., Tsuboi, N., Mizuno, M., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x655019 · Cited by 60
External factors influencing mesenchymal stem cell fate in vitro
Sisakhtnezhad, S., Alimoradi, E., & Akrami, H. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.11.003 · Cited by 70
Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models
Crigna, A. T., Daniele, C., Gamez, C., Balbuena, S. M., Pastene, D. O., Nardozi, D., Brenna, C., Yard, B. A., Gretz, N., & Bieback, K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00179 · Cited by 65
“MSC can be isolated from a variety of adult or fetal sources like bonemarrow, adipose tissue (ASC), periosteum, synovium, dental pulp, fetal tissues, umbilical cord tissue (UC), umbilical cord blood (UCB), placenta, and amniotic fluids (8, 9).”
BackgroundSelf-citationJayaram, P., Ikpeama, U. E., Rothenberg, J. B., & Malanga, G. A. (2018) · PM&R · doi:10.1016/j.pmrj.2018.06.019 · Cited by 68
“that characterizes MSCs as cells with a thin elongated morphology, plastic adherent, anti-inflammatory, antiapoptotic, antifibrotic, and have immunomodulatory capability [6].”
BackgroundMahaira, L. G., Katsara, O., Pappou, E., Iliopoulou, E. G., Fortis, S. P., Antsaklis, A., Fotinopoulos, P., Baxevanis, C. N., Papamichail, M., & Perez, S. A. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0604 · Cited by 63
“Since then, great progress has been made and MSCs have been found in almost all tissues, including adipose tissue (AT), umbilical cord (UC), and umbilical cord blood (UCB) [2] while there is also evidence that they differentiate toward various lineages, such as neuroectoderm and epithelium [3].”
Freitas, G. P., Lopes, H. B., Souza, A. T. P., de Oliveira, P. G. F. P., Almeida, A. L. G., de Souza, L. E. B., Coelho, P. G., Beloti, M. M., & Rosa, A. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-50067-6 · Cited by 67
Olmedo-Moreno, L., Aguilera, Y., Baliña-Sánchez, C., Martín‐Montalvo, A., & Capilla‐González, V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051112 · Cited by 63
“For instance, reports have demonstrated that Ad-MSCs derived from diabetic patients with critical limb ischemia possess a defective phenotype and exhibit a prothrombotic profile, which was associated with the development of microthrombosis after autologous cell infusion [14,50].”
ResultInfluentialObese-derived ASCs show impaired migration and angiogenesis properties
Pérez, L. M., Bernal, A., Martín, N. S., & Gálvez, B. G. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.784339 · Cited by 61
Pleumeekers, M. M., Nimeskern, L., Koevoet, W. L., Kops, N., Poublon, R. M. L., Stok, K. S., & van Osch, G. (2014) · European Cells and Materials · doi:10.22203/ecm.v027a19 · Cited by 66
Mesenchymal Stem Cells and Their Cell Surface Receptors
Docheva, D., Haasters, F., & Schieker, M. (2008) · Current Rheumatology Reviews · doi:10.2174/157339708785133479 · Cited by 73
“For example, adipose tissue-derived MSCs have much lower CD106 expression and lack Stro-1 antigen in comparison to MSCs that have originated from BM [15, 16].”
BackgroundComparison of endometrial regenerative cells and bone marrow stromal cells
Wang, H., Jin, P., Sabatino, M., Ren, J., Civini, S., Bogin, V., Ichim, T. E., & Stroncek, D. F. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-207 · Cited by 62
Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile
Wu, Y., Hoogduijn, M. J., Baan, C. C., Korevaar, S. S., de Kuiper, R., Yan, L., Wang, L., & van Besouw, N. M. (2017) · Stem Cells International · doi:10.1155/2017/4960831 · Cited by 59
“MSC are found in all tissues [30] and in the search of finding the most assessable, best expandable, and most effective MSC type for therapy, remarkable similarities concerning surface antigen expression, immunosuppressive activity, and differentiation ability betweenMSC of different tissue sources have been observed…”
BackgroundAdipose-derived stem cells for treatment of chronic ulcers: current status
Holm, J. S., Toyserkani, N. M., & Sørensen, J. A. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0887-0 · Cited by 59
“Adipose tissue is an excellent source of autologous ADSC and can be harvested easily compared with bone marrowderived stem cells (BMSC) [15].”
BackgroundInfluentialLee, S. E., Lee, S., Kim, S., Kim, K., Cho, B., Roh, K.-H., & Kim, S. (2021) · JCI Insight · doi:10.1172/jci.insight.143606 · Cited by 60
Lee, N., Na, S.-M., Ahn, H.-W., Kang, J.-K., Seon, J. K., & Song, E. K. (2021) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2021.02.022 · Cited by 62
Khamis, T., Abdelalim, A. F., Saeed, A. A., Edress, N. M., Nafea, A. E., Ebian, H. F., Algendy, R. M., Hendawy, D. M., Arisha, A. H., & Abd-Allah, S. H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174188 · Cited by 67
Strecanska, M., Sekelova, T., Smolinská, V., Kuniaková, M., & Nicodemou, A. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10812-5 · Cited by 59
“Generally, the initial frequency of MSCs in native tissues and collected biological material is very low – it was reported less than or about one MSCs per 10 4 –10 5 mononuclear cells in bone marrow, or per 10 2 –10 3 cells from lipoaspirate respectively [5].”
Luzzani, C., Neiman, G., Garate, X., Questa, M., Solari, C., Espinosa, D. F., García, M. N., Errecalde, A. L., Guberman, A., Scassa, M. É., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/scrt540 · Cited by 58
Liu, G., Li, Y., Sun, J. H., Zhou, H., Zhang, W., Cui, L., & Cao, Y. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0516 · Cited by 62
Mesenchymal stromal cells (MSCs): science and f(r)iction
Bieback, K., Wuchter, P., Besser, D., Franke, W. W., Becker, M., Ott, M., Pacher, M., Ma, N., Stamm, C., Klüter, H., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0915-y · Cited by 64
“Consistently, the differentiation potential as well as the functional characteristics varied significantly among MSC preparations derived from different sources or cultured under different conditions [8, 83].”
BackgroundSelf-citation
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.